{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05911295",
            "orgStudyIdInfo": {
                "id": "SGNDV-001"
            },
            "secondaryIdInfos": [
                {
                    "id": "KEYNOTE-D74",
                    "type": "OTHER",
                    "domain": "Merck Sharp & Dohme LLC"
                },
                {
                    "id": "MK-3475-D74",
                    "type": "OTHER",
                    "domain": "Merck Sharp & Dohme LLC"
                },
                {
                    "id": "2022-501105-12",
                    "type": "REGISTRY",
                    "domain": "CTIS (EU)"
                }
            ],
            "organization": {
                "fullName": "Seagen Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2",
            "officialTitle": "An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination With Pembrolizumab Versus Chemotherapy in Subjects With Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma That Expresses HER2 (IHC 1+ and Greater)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "disitamab-vedotin-with-pembrolizumab-vs-chemotherapy-in-previously-untreated-urothelial-cancer-expressing"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-09",
            "studyFirstSubmitQcDate": "2023-06-09",
            "studyFirstPostDateStruct": {
                "date": "2023-06-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Seagen Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "RemeGen Co., Ltd.",
                    "class": "INDUSTRY"
                },
                {
                    "name": "Merck Sharp & Dohme LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease.\n\nParticipants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced).\n\nIn this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Urothelial Carcinoma"
            ],
            "keywords": [
                "Urothelial Cancer",
                "LA/mUC",
                "Bladder Cancer",
                "HER2 Overexpression",
                "HER2 Amplification",
                "HER2",
                "Seattle Genetics"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 700,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Disitamab vedotin arm",
                    "type": "EXPERIMENTAL",
                    "description": "disitamab vedotin + pembrolizumab",
                    "interventionNames": [
                        "Drug: disitamab vedotin",
                        "Drug: pembrolizumab"
                    ]
                },
                {
                    "label": "Standard of care arm",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "gemcitabine + cisplatin OR carboplatin",
                    "interventionNames": [
                        "Drug: gemcitabine",
                        "Drug: cisplatin",
                        "Drug: carboplatin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "disitamab vedotin",
                    "description": "Given into the vein (IV; intravenous) every 2 weeks",
                    "armGroupLabels": [
                        "Disitamab vedotin arm"
                    ],
                    "otherNames": [
                        "RC48, RC48-ADC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "pembrolizumab",
                    "description": "400mg given by IV every 6 weeks",
                    "armGroupLabels": [
                        "Disitamab vedotin arm"
                    ],
                    "otherNames": [
                        "KEYTRUDA\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "gemcitabine",
                    "description": "1000 mg/m\\^2 given by IV on days 1 and 8 of every 3-week cycle",
                    "armGroupLabels": [
                        "Standard of care arm"
                    ],
                    "otherNames": [
                        "Gemzar"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "cisplatin",
                    "description": "70 mg\\^2 given by IV on day 1 of every 3-week cycle",
                    "armGroupLabels": [
                        "Standard of care arm"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "carboplatin",
                    "description": "Area under the plasma concentration-time curve (AUC) 4.5 or 5 given by IV on day 1 of every 3-week cycle",
                    "armGroupLabels": [
                        "Standard of care arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by blinded independent central review (BICR)",
                    "description": "The time from randomization to first documentation of disease progression per RECIST v1.1 by BICR, or to death due to any cause.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "The time from date of randomization to date of death due to any cause.",
                    "timeFrame": "Approximately 5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Objective response rate (ORR) per RECIST v1.1 by BICR",
                    "description": "The proportion of participants with confirmed complete response (CR) or partial response (PR) according to RECIST v1.1.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "ORR per RECIST v1.1 by investigator assessment",
                    "description": "The proportion of participants with confirmed CR or PR according to RECIST v1.1.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Duration of Response (DOR) per RECIST v1.1 by BICR",
                    "description": "The time from first documented response of CR or PR (that is subsequently confirmed) to the first documented disease progression per RECIST v1.1, or to death due to any cause.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "DOR per RECIST v1.1 by investigator assessment",
                    "description": "The time from first documented response of CR or PR (that is subsequently confirmed) to the first documented disease progression per RECIST v1.1, or to death due to any cause.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Control Rate (DCR) per RECIST v1.1 by BICR",
                    "description": "The proportion of participants with confirmed CR, PR, or stable disease according to RECIST v1.1.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "DCR per RECIST v1.1 by investigator assessment",
                    "description": "The proportion of participants with confirmed CR, PR, or stable disease according to RECIST v1.1.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "PFS per RECIST v1.1 by investigator assessment",
                    "description": "The time from randomization to first documentation of disease progression per RECIST v1.1, or to death due to any cause.",
                    "timeFrame": "Approximately 3 years"
                },
                {
                    "measure": "Number of participants with adverse events (AEs)",
                    "description": "Any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Through 30 days after the last study treatment; approximately 2 years"
                },
                {
                    "measure": "Number of participants with laboratory abnormalities",
                    "timeFrame": "Through 30 days after the last study treatment; approximately 2 years"
                },
                {
                    "measure": "Treatment discontinuation rate due to AEs",
                    "timeFrame": "Approximately 2 years"
                },
                {
                    "measure": "Number of electrocardiogram (ECG) abnormalities",
                    "timeFrame": "Through 30 days after the last study treatment; approximately 2 years"
                },
                {
                    "measure": "Change from baseline of left ventricular ejection fraction (LVEF)",
                    "timeFrame": "Through 2 years after last study treatment; approximately 4 years"
                },
                {
                    "measure": "Change from baseline to Week 16 in European Organization for Research and Treatment of Cancer core Quality of Life questionnaire (EORTC QLQ-C30) Global Health Status (GHS)/QoL Score",
                    "description": "The EORTC QLQ-C30 is used to evaluate health-related quality of life, functioning, disease symptoms, and treatment-related side effects. Scores range from 0-100. For GHS/QoL and functional scales, higher scores represent higher QoL or functioning. For symptom scales, higher scores represent more symptoms/worse status.",
                    "timeFrame": "Approximately 2 years"
                },
                {
                    "measure": "Time to Deterioration in EORTC QLQ-C30 GHS/QoL Score",
                    "description": "The time from the date of randomization to the date of first deterioration (change from baseline \u226510) in GHS/QoL score with no subsequent recovery. The EORTC QLQ-C30 is used to evaluate health-related quality of life, functioning, disease symptoms, and treatment-related side effects. Scores range from 0-100. For GHS/QoL and functional scales, higher scores represent higher QoL or functioning. For symptom scales, higher scores represent more symptoms/worse status.",
                    "timeFrame": "Approximately 2 years"
                },
                {
                    "measure": "Time to pain progression",
                    "description": "The time from the date of randomization to whichever of the following occurs earlier:\n\n* an increase in Numeric Rating Scale (NRS) for pain intensity of 2 points or more from baseline at 2 consecutive visits,\n* an increase in number of opioid or analgesic use from baseline,\n* or initiation of opioid or analgesic use. NRS for pain intensity asks participants to best describe their pain at its worst in the last 24 hours from 0 to 10. On the NRS, 0 means no pain and 10 means pain as bad as you can imagine.",
                    "timeFrame": "Approximately 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histopathological confirmation of locally advanced unresectable or metastatic urothelial carcinoma (LA/mUC), including UC originating from the renal pelvis, ureters, bladder, or urethra.\n* Measurable disease by investigator assessment per RECIST v1.1.\n* Participant must not have received prior systemic therapy for LA/mUC. Exception will be made for neoadjuvant or adjuvant therapy, if disease recurrence/progression occurred more than 12 months after the last dose of therapy.\n* Eligible to receive cisplatin- or carboplatin-containing chemotherapy.\n* Able to provide archived formalin-fixed paraffin-embedded tumor tissue blocks from a muscle-invasive or metastatic UC lesion or biopsy of metastatic UC prior to treatment initiation. If archival tissue is not available a newly obtained baseline biopsy of an accessible tumor lesion is required within 28 days of cycle 1 day 1.\n* HER2 expression of 1+ or greater on immunohistochemistry (IHC).\n* Eastern Cooperative Oncology Group (ECOG) performance score of 0, 1, or 2 within 7 days prior to randomization.\n\nExclusion Criteria:\n\n* Known hypersensitivity to disitamab vedotin, cisplatin, carboplatin, gemcitabine, or pembrolizumab or any of their components.\n* History of severe/life threatening immune-related adverse event (irAE) with PD-(L)1 inhibitors are excluded.\n* Central nervous system (CNS) and/or leptomeningeal metastasis. Participants with treated CNS metastases are permitted if all of the following are met.\n\n  * CNS metastases have been clinically stable for at least 4 weeks and baseline scans show no evidence of new or worsening CNS metastasis.\n  * Participant is on a stable dose of \u2264 10 mg/day of prednisone or equivalent for at least 2 weeks.\n* History of or active autoimmune disease that has required systemic treatment in the past 2 years.\n* Prior treatment with an agent directed to another stimulatory or co-inhibitory T cell receptor (including but not limited to CD137 agonists, CAR-T cell therapy, CTLA-4 inhibitors, or OX-40 agonists).\n* Prior solid organ or bone marrow transplantation.\n* Pleural effusion or ascites with symptoms or requiring symptomatic treatment.\n* Estimated life expectancy \\<12 week\n* Prior treatment with an MMAE agent or anti-HER2 therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Seagen Trial Information Support",
                    "role": "CONTACT",
                    "phone": "866-333-7436",
                    "email": "clinicaltrials@seagen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Monitor",
                    "affiliation": "Seagen Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Alaska Oncology and Hematology",
                    "status": "COMPLETED",
                    "city": "Anchorage",
                    "state": "Alaska",
                    "zip": "99508",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 61.21806,
                        "lon": -149.90028
                    }
                },
                {
                    "facility": "Banner MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Gilbert",
                    "state": "Arizona",
                    "zip": "85234",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Isaac Bowman",
                            "role": "CONTACT",
                            "phone": "347-673-9487",
                            "email": "isaac.bowman@bannerhealth.com"
                        },
                        {
                            "name": "Isaac Bowman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.35283,
                        "lon": -111.78903
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope & Innovation - California",
                    "status": "RECRUITING",
                    "city": "Cerritos",
                    "state": "California",
                    "zip": "90703",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pamela Miel",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "pmiel@airesearch.us"
                        },
                        {
                            "name": "Pamela Miel",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.85835,
                        "lon": -118.06479
                    }
                },
                {
                    "facility": "Los Angeles Cancer Network / Compassionate Care Research Group",
                    "status": "RECRUITING",
                    "city": "Fountain Valley",
                    "state": "California",
                    "zip": "92708",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eric H Lee",
                            "role": "CONTACT",
                            "phone": "714-698-0300",
                            "email": "ericlee@compcancercare.com"
                        },
                        {
                            "name": "Eric H Lee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.70918,
                        "lon": -117.95367
                    }
                },
                {
                    "facility": "University of California Los Angeles Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexandra Drakaki",
                            "role": "CONTACT",
                            "phone": "210-206-6766",
                            "email": "adrakaki@mednet.ucla.edu"
                        },
                        {
                            "name": "Alexandra Drakaki",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Pacific Cancer Care",
                    "status": "RECRUITING",
                    "city": "Monterey",
                    "state": "California",
                    "zip": "93940",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Zachary Koontz",
                            "role": "CONTACT",
                            "phone": "831-375-4105",
                            "email": "koontz@pacificcancercare.com"
                        },
                        {
                            "name": "Michael Zachary Koontz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.60024,
                        "lon": -121.89468
                    }
                },
                {
                    "facility": "Kaiser Permanente Southern California",
                    "status": "RECRUITING",
                    "city": "Riverside",
                    "state": "California",
                    "zip": "92505",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Helen Moon",
                            "role": "CONTACT",
                            "phone": "951-353-3323",
                            "email": "Helen.H.Moon@kp.org"
                        },
                        {
                            "name": "Helen Moon",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.95335,
                        "lon": -117.39616
                    }
                },
                {
                    "facility": "University of California, San Francisco | HDFCCC - Hematopoietic Malignancies",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vadim Koshkin",
                            "role": "CONTACT",
                            "phone": "773-837-0783",
                            "email": "vadim.koshkin@ucsf.edu"
                        },
                        {
                            "name": "Vadim Koshkin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Providence Medical Foundation",
                    "status": "COMPLETED",
                    "city": "Santa Rosa",
                    "state": "California",
                    "zip": "95403",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.44047,
                        "lon": -122.71443
                    }
                },
                {
                    "facility": "PIH Health Hospital Whittier",
                    "status": "RECRUITING",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90602",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisa Wang, MD",
                            "role": "CONTACT",
                            "phone": "562-789-5480",
                            "email": "Lisa.Wang@pihhealth.org"
                        },
                        {
                            "name": "Lisa Wang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "Decatur Memorial Hospital - Illinois",
                    "status": "COMPLETED",
                    "city": "Decatur",
                    "state": "Illinois",
                    "zip": "62526",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.84031,
                        "lon": -88.9548
                    }
                },
                {
                    "facility": "Illinois Cancer Care",
                    "status": "COMPLETED",
                    "city": "Peoria",
                    "state": "Illinois",
                    "zip": "61615",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.69365,
                        "lon": -89.58899
                    }
                },
                {
                    "facility": "Siouxland Regional Cancer Center dba June E. Nylen Cancer Center",
                    "status": "RECRUITING",
                    "city": "Sioux City",
                    "state": "Iowa",
                    "zip": "51101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Donald Wender",
                            "role": "CONTACT",
                            "phone": "712-252-0088",
                            "email": "wenderd@jencc.com"
                        },
                        {
                            "name": "Donald Wender",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.49999,
                        "lon": -96.40031
                    }
                },
                {
                    "facility": "Greater Baltimore Medical Center (GBMC) - Sandra & Malcolm Berman Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Celano",
                            "role": "CONTACT",
                            "phone": "443-849-3051",
                            "email": "pcelano@gbmc.org"
                        },
                        {
                            "name": "Paul Celano",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "HealthPartners Institute",
                    "status": "RECRUITING",
                    "city": "Saint Louis Park",
                    "state": "Minnesota",
                    "zip": "55426",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yan Ji",
                            "role": "CONTACT",
                            "phone": "608-698-5962",
                            "email": "yan.x.ji@healthpartners.com"
                        },
                        {
                            "name": "Yan Ji",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.9483,
                        "lon": -93.34801
                    }
                },
                {
                    "facility": "University of Mississippi Medical Center",
                    "status": "RECRUITING",
                    "city": "Jackson",
                    "state": "Mississippi",
                    "zip": "39216",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Henegan",
                            "role": "CONTACT",
                            "phone": "601-984-5590",
                            "email": "jhenegan@umc.edu"
                        },
                        {
                            "name": "John Henegan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.29876,
                        "lon": -90.18481
                    }
                },
                {
                    "facility": "Cancer Partners of Nebraska",
                    "status": "COMPLETED",
                    "city": "Lincoln",
                    "state": "Nebraska",
                    "zip": "68516",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.8,
                        "lon": -96.66696
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198-6840",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Benjamin Teply",
                            "role": "CONTACT",
                            "phone": "402-559-5166",
                            "email": "ben.teply@unmc.edu"
                        },
                        {
                            "name": "Benjamin Teply",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "North Shore Center for Advanced Medicine Monter Cancer Center / North Shore University Hospital",
                    "status": "RECRUITING",
                    "city": "Lake Success",
                    "state": "New York",
                    "zip": "11042",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Thomas P Bradley",
                            "role": "CONTACT",
                            "phone": "516-734-7688",
                            "email": "tbradley@northwell.edu"
                        },
                        {
                            "name": "Thomas P Bradley",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.77066,
                        "lon": -73.71763
                    }
                },
                {
                    "facility": "Mount Sinai Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Galsky",
                            "role": "CONTACT",
                            "phone": "212-659-5452",
                            "email": "matthew.galsky@mssm.edu"
                        },
                        {
                            "name": "Matthew Galsky",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Levine Cancer Institute",
                    "status": "COMPLETED",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "MidLantic Urology",
                    "status": "COMPLETED",
                    "city": "Bala-Cynwyd",
                    "state": "Pennsylvania",
                    "zip": "19004",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.00761,
                        "lon": -75.23407
                    }
                },
                {
                    "facility": "Allegheny General Hospital",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15212",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shifeng S Mao",
                            "role": "CONTACT",
                            "phone": "412-359-6147",
                            "email": "shifeng.mao@ahn.org"
                        },
                        {
                            "name": "Shifeng S Mao",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "West Cancer Center & Research Institute",
                    "status": "COMPLETED",
                    "city": "Germantown",
                    "state": "Tennessee",
                    "zip": "38138",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.08676,
                        "lon": -89.81009
                    }
                },
                {
                    "facility": "Thompson Cancer Survival Center",
                    "status": "RECRUITING",
                    "city": "Knoxville",
                    "state": "Tennessee",
                    "zip": "37916",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Dewayne Chism",
                            "role": "CONTACT",
                            "phone": "865-541-1678",
                            "email": "dchism@CovHlth.com"
                        },
                        {
                            "name": "David Dewayne Chism",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.96064,
                        "lon": -83.92074
                    }
                },
                {
                    "facility": "University of Tennessee",
                    "status": "COMPLETED",
                    "city": "Knoxville",
                    "state": "Tennessee",
                    "zip": "37920",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.96064,
                        "lon": -83.92074
                    }
                },
                {
                    "facility": "US Oncology Central Regulatory",
                    "status": "COMPLETED",
                    "city": "The Woodlands",
                    "state": "Texas",
                    "zip": "77380",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.15799,
                        "lon": -95.48938
                    }
                },
                {
                    "facility": "Providence Regional Medical Center Everett",
                    "status": "COMPLETED",
                    "city": "Everett",
                    "state": "Washington",
                    "zip": "98201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.97898,
                        "lon": -122.20208
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Evan Yu",
                            "role": "CONTACT",
                            "phone": "206-288-7222",
                            "email": "evanyu@uw.edu"
                        },
                        {
                            "name": "Evan Yu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Medical College of Wisconsin (Milwaukee)",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ariel Nelson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Macquarie University Hospital",
                    "status": "RECRUITING",
                    "city": "Brisbane",
                    "state": "Other",
                    "zip": "2109",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Alison Zhang",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.46794,
                        "lon": 153.02809
                    }
                },
                {
                    "facility": "Icon Cancer Care Chermside",
                    "status": "RECRUITING",
                    "city": "Chermside",
                    "state": "Other",
                    "zip": "4032",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Chun Loo Gan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.38472,
                        "lon": 153.03062
                    }
                },
                {
                    "facility": "Lyell McEwin Hospital",
                    "status": "RECRUITING",
                    "city": "Elizabeth Vale",
                    "state": "Other",
                    "zip": "5112",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Christopher Hocking",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.74857,
                        "lon": 138.66819
                    }
                },
                {
                    "facility": "Peninsula and South East Oncology",
                    "status": "RECRUITING",
                    "city": "Frankston",
                    "state": "Other",
                    "zip": "3199",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Sanjeev Sewak",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.14458,
                        "lon": 145.12291
                    }
                },
                {
                    "facility": "Tom Baker Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Calgary",
                    "state": "Alberta",
                    "zip": "T2N4N2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Nimira Alimohamed",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.05011,
                        "lon": -114.08529
                    }
                },
                {
                    "facility": "University of Alberta / Cross Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Naveen Basappa",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "British Columbia Cancer Agency - Vancouver Centre",
                    "status": "RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V5Z 4E6",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Bernhard Eigl",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "Lakeridge Health - The R.S. McLaughlin Durham Regional Cancer Centre (MDRCC)",
                    "status": "RECRUITING",
                    "city": "Oshawa",
                    "state": "Ontario",
                    "zip": "L1G 2B9",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Pawel Zalewski",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.90012,
                        "lon": -78.84957
                    }
                },
                {
                    "facility": "University Health Network, Princess Margaret Hospital",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Other",
                    "zip": "M5G 2C1",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Srikala Sridhar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "National University Hospital",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "state": "Other",
                    "zip": "119228",
                    "country": "Singapore",
                    "contacts": [
                        {
                            "name": "Alvin Wong",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "National Cancer Centre Singapore",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "state": "Other",
                    "zip": "169610",
                    "country": "Singapore",
                    "contacts": [
                        {
                            "name": "Ravindran Kanesvaran",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "state": "Other",
                    "zip": "10002",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Yu-Chieh Tsai",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002295",
                    "term": "Carcinoma, Transitional Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5551",
                    "name": "Carcinoma, Transitional Cell",
                    "asFound": "Urothelial Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T5693",
                    "name": "Transitional Cell Carcinoma",
                    "asFound": "Urothelial Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016190",
                    "term": "Carboplatin"
                },
                {
                    "id": "D000093542",
                    "term": "Gemcitabine"
                },
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "C000722994",
                    "term": "Disitamab vedotin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18650",
                    "name": "Carboplatin",
                    "asFound": "System",
                    "relevance": "HIGH"
                },
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2985",
                    "name": "Gemcitabine",
                    "asFound": "Mg/kg",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M240270",
                    "name": "Disitamab vedotin",
                    "asFound": "Adebrelimab",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}